vVARDIS is a developer and manufacturer of dental products under the Curodont brand, including its innovative drill-free treatment for early tooth decay. Thousands of dental clinics are using the product, with over 300,000 teeth treated last year. vVARDIS’ technology is already incorporated in lectures of renowned universities in the U.S. and Europe as a new standard of care for the treatment of early tooth decay.
Haley and Goly Abivardi, founders and co-CEOs of vVARDIS, said, “We are thrilled about the partnership with OrbiMed. The funding and the expertise they bring will enhance our abilities to better serve dental professionals and patients and to fulfil our vision to create a world where treatment of early decay is pain-free, regenerative and accessible to everyone.
“As dentists, we are excited to finally offer a solution for the treatment of early decay. Dental professionals have been waiting for decades for a drill-free treatment of early decay. Curodont has the potential to broaden the scope of options offered by dental practices and empowering them to enhance patient care.”
The partnership between OrbiMed and vVARDIS is based on the shared vision to build a global leader in innovative dental products. According to vVardis, with the market shifting from invasive to non-invasive care, combined with the accelerated adoption of AI-detection of early tooth decay, its products are well-timed to market trends. The company’s products allow dental practices to treat early tooth decay in five to 10 minutes, saving dental professionals and patients hours of chair time.
Matthew Rizzo, general partner at OrbiMed, said, “We are confident that vVARDIS has the scientific knowledge and capabilities to become a global powerhouse in the dental market. With its proprietary formulas and its Curodont products, the company is positioned to grow fast in this market and to provide a drill-free option for early tooth decay. The growth ambition of the company and its focus on providing innovative solutions in a global dental market are at the core of our investment strategy.”
For more information visit www.vVARDIS.com